Bibliographic Details
| Title: |
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study. |
| Authors: |
Burge DJ; Trubion Pharmaceuticals Inc., Seattle, Washington, USA., Bookbinder SA, Kivitz AJ, Fleischmann RM, Shu C, Bannink J |
| Source: |
Clinical therapeutics [Clin Ther] 2008 Oct; Vol. 30 (10), pp. 1806-16. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article |
| Journal Info: |
Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print Cited Medium: Print ISSN: 0149-2918 (Print) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
